Monovalent type 2 OPV (mOPV2) management in the field: Interventions and lessons learned.

A, Afsar; A, Mallya; AAG, Mohammed; S, Anand; VKF, Diomande; du Châtellier G, Maufras; F, Ather

doi:10.1016/j.vaccine.2022.12.033

Public

Monovalent type 2 OPV (mOPV2) management in the field: Interventions and lessons learned.

Shared by NobleBlocks on Jan 13, 2023 • 12:00 AM UTC

Authors:

Afsar A

Mallya A

Mohammed AAG

Abstract

The polio endgame strategy calls for ending the use of and removal of all Sabin vaccines globally given the risks of generation and spread of cVDPVs. With the successful eradication of wild poliovirus type 2 in 2015, the process of removing type 2 Sabin vaccines began with the switch from tOPV to bO...

Subject

Oral Polio Vaccine

Polio

Reverse Logistics

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!